eu

Cellectis and AstraZeneca in US$2.2bn deal
  1. Biotechnology

Cellectis and AstraZeneca in US$2.2bn deal

AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in equity in an US$2.2bn R&D deal for up to ten cell and gene therapies. Under the co-development agreement, that includes a US$80m equity investment and an option for a further equity investment of US$140m by AstraZeneca plc into Cellectis […]
Written by
BioNtech reports Car-T/mRNA booster study results at ESMO
  1. Biotechnology

BioNtech reports Car-T/mRNA booster study results at ESMO

BioNtech SE has reported preliminary Phase I/II results with BNT211-01 (NEO-PTC-01) and CarVAC at ESMO conference in Madrid Testing different dose levels of its adoptive cell therapy BNT.221-01, a combination of Claudin 6 (CLDN6)-targeted Car-T cells (derived from NEO-PTC-01, initially developed by tody’s BioNTech subsidiary Neon Therapeutics) and the mRNA-based Car-T  booster CarVac (CAR-T cell […]
Written by
Antiverse and GlobalBio Inc. extend collaboration
  1. Biotechnology

Antiverse and GlobalBio Inc. extend collaboration

Antiverse Ltd and GlobalBio Inc. have extend their cancer antibody partnership to progress two PD-1 modulators to preclinial development AI specialist Antiverse Ltd (Cardiff, UK) and antobody engeeniering expert GlobalBio, Inc. (New York, USA) will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy. The initial collaboration successfully resulted in the generation […]
Written by
SpliceBio has made up a US $216m alliance with Spark Therapeutics
  1. Biotechnology

SpliceBio has made up a US $216m alliance with Spark Therapeutics

SpliceBio has licenced its intein technlogy to Roche’s gene therapy subsidiary Spark Therapeutics to develop a gene therapy targeting an undisclosed inherited retinal disease. Under a globally exclusive licence option agreement with Roche AG, SpliceBio secures an upfront payment, opt-in and milestone payments up to $216m plus royalties in exchange to its recombinant split […]
Written by

Good Reads

Bacteriophage Characterization Paves the Way for Rational Design

In a groundbreaking advancement for virology and structural biology, researchers at the Okinawa Institute of Science and Technology (OIST) and the University of Otago have meticulously elucidated the complete high-resolution structure of the bacteriophage Bas63, a virus known for its specificity in targeting Escherichia coli bacteria. Utilizing state-of-the-art cryogenic electron microscopy (cryo-EM), this study unveils […]
Written by

Worlwide

Bacteriophage Characterization Paves the Way for Rational Design

In a groundbreaking advancement for virology and structural biology, researchers at the Okinawa Institute of Science and Technology (OIST) and the University of Otago have meticulously elucidated the complete high-resolution structure of the bacteriophage Bas63, a virus known for its specificity in targeting Escherichia coli bacteria. Utilizing state-of-the-art cryogenic electron microscopy (cryo-EM), this study unveils […]
Written by

Fish Group Casino slot games Complete Opinion and you may Totally free Megawin login Trial Online game

In the center of a sunshine-baked wood physical stature, the brand new reels is full of colourful icons. This can be a pretty diversity, which is great news to possess people who like to enjoy to your several different numbers. You can even be assured with the knowledge that you’ll will have a high probability […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.